BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15458828)

  • 1. TGFbeta1 regulation and collagen-release-independent connective tissue re-modelling by the ruthenium complex NAMI-A in solid tumours.
    Casarsa C; Mischis MT; Sava G
    J Inorg Biochem; 2004 Oct; 98(10):1648-54. PubMed ID: 15458828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
    Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G
    Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
    Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
    Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
    Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
    Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
    Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
    Pacor S; Zorzet S; Cocchietto M; Bacac M; Vadori M; Turrin C; Gava B; Castellarin A; Sava G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):737-44. PubMed ID: 15075381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
    Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine.
    Sava G; Gagliardi R; Bergamo A; Alessio E; Mestroni G
    Anticancer Res; 1999; 19(2A):969-72. PubMed ID: 10368640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process.
    Brescacin L; Masi A; Sava G; Bergamo A
    J Biol Inorg Chem; 2015 Oct; 20(7):1163-73. PubMed ID: 26369538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.
    Sava G; Frausin F; Cocchietto M; Vita F; Podda E; Spessotto P; Furlani A; Scarcia V; Zabucchi G
    Eur J Cancer; 2004 Jun; 40(9):1383-96. PubMed ID: 15177498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
    Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G
    Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
    Zorzet S; Bergamo A; Cocchietto M; Sorc A; Gava B; Alessio E; Iengo E; Sava G
    J Pharmacol Exp Ther; 2000 Dec; 295(3):927-33. PubMed ID: 11082425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells.
    Liu G; Ding W; Liu X; Mulder KM
    Mol Carcinog; 2006 Aug; 45(8):582-93. PubMed ID: 16637060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour cell uptake G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells.
    Bergamo A; Zorzet S; Cocchietto M; Carotenuto ME; Magnarin M; Sava G
    Anticancer Res; 2001; 21(3B):1893-8. PubMed ID: 11497274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-A.
    Bergamo A; Pelillo C; Chambery A; Sava G
    J Inorg Biochem; 2017 Mar; 168():90-97. PubMed ID: 28064102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells.
    Frausin F; Cocchietto M; Bergamo A; Scarcia V; Furlani A; Sava G
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):405-11. PubMed ID: 12439599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of penile fibrosis model in a rat using mouse NIH 3T3 fibroblasts expressing transforming growth factor beta1.
    Ryu JK; Song SU; Han JY; Chu YC; Lee M; Kim JS; Kim SJ; Suh JK
    Biol Reprod; 2005 Apr; 72(4):916-21. PubMed ID: 15601922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A.
    Pelillo C; Mollica H; Eble JA; Grosche J; Herzog L; Codan B; Sava G; Bergamo A
    J Inorg Biochem; 2016 Jul; 160():225-35. PubMed ID: 26961176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.